C1-esterase inhibitor

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 01.08.2022

Dieser Artikel auf Deutsch

Synonym(s)

C1-INH

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Glycoprotein (105 KDa), which is predominantly formed in hepatocytes, consists of 487 amino acids and regulates the activation of complement factor C1.

General informationThis section has been translated automatically.

The human C1 esterase inhibitor gene is located on the eleventh chromosome (11q11-q13.1). Deficiency of the C1 esterase inhibitor leads to activation of the complement system, which in turn leads to low plasma concentrations of complement factor C2. It is currently believed that cleaved C2 increases the permeability of vascular walls. Furthermore, it has long been hypothesized that inhibitor deficiency results in increased kallikrein and, consequently, increased bradykinin, which causes the subcutaneous swelling seen in typeI hereditary angioedema. Elevated levels of bradykinin have been noted in acute swellings.

LaboratoryThis section has been translated automatically.

The standard value in the blood is about 0.25-0.45 g/l.

LiteratureThis section has been translated automatically.

  1. Zuraw BL (2006) Novel therapies for hereditary angioedema. Immunol Allergy Clin North Am 26: 691-708
  2. Levy JH et al (2006) The therapeutic potential of a kallikrein inhibitor for treating hereditary angioedema. Expert Opinion Investig Drugs 15: 1077-1090

Authors

Last updated on: 01.08.2022